Long intergenic non-protein coding RNA 1861 (LINC01861)

LINC01861 (Long intergenic non-protein coding RNA 1861) is a human long intergenic non-coding RNA (lincRNA) gene. LincRNAs are a subclass of non-coding RNAs longer than 200 nucleotides, transcribed independently without overlapping protein-coding genes[1][3][5]. These RNAs play diverse biological roles, especially in the regulation of gene expression, often through epigenetic mechanisms. Although many lincRNAs, as a class, have been implicated in regulating the cell cycle, apoptosis, immunity, and development, and some have identified roles in disease (e.g., cancer, autoimmune diseases, neurodegenerative diseases), there is currently no evidence that LINC01861 itself acts as a direct therapeutic target or has specific, experimentally validated biological or disease functions[1][3][5]. LincRNAs are emerging as possible biomarkers and therapeutic targets in general, but LINC01861's specific interactions, mechanisms of action, or disease associations are not yet established in the literature surveyed[1][3][5].

Other names

LINC01861